Topics

Glioblastoma | Treatment | Off-label Medications | Antisecretory factor

Home > Publications > Topics > Glioblastoma > Treatment > Off-label Medications > Antisecretory factor

Ehinger E, Darabi A, Visse E, Edvardsson C, Tomasevic G, Cederberg D, Kinhult S, Rydelius A, Nilsson C, Belting M, Bengzon J, Siesjö P.
Antisecretory factor as add-on treatment for newly diagnosed glioblastoma, IDH wildtype: study protocol for a randomized double-blind placebo-controlled trial.
Trials. 2025 Mar 13;26(1):86. doi: 10.1186/s13063-025-08792-z. PMID: 40083039. Interventional study protocol. ˍ